Overprescribed

Antidepressants, Imodium A-D & Inhaler Product Issues

Informações:

Synopsis

In Episode #11, we're talking about another QuarterWatch report (May 2018) from the Institute for Safe Medication Practices, or ISMP.  The report touches on the topic of antidepressant effectiveness, a big public health issue related to the popular anti-diarrheal medication Imodium A-D, and the crazy confusion and dispensing errors related to four product inhalers currently on the market and being sold under the brand Ellipta. Show note links: To read the QuarterWatch May 2018 report, click here. To learn more about the ISMP, click here. "In the News" --> Amazon bought PillPack! Read about it here. Got a news story, question, or insider tip on a medication issue threatening consumer health? Email us at talk@overprescribedpodcast.com

Join Now

Join Now

  • Unlimited access to all content on the platform.
  • More than 30 thousand titles, including audiobooks, ebooks, podcasts, series and documentaries.
  • Narration of audiobooks by professionals, including actors, announcers and even the authors themselves.
Try it Now Firm without compromise. Cancel whenever you want.

Share